May 5, 2020 / 11:40 AM / a month ago

BRIEF-InMed Pharmaceuticals Says Co Working With Almac Group On Proprietary Approach To Augment Current Biosynthesis-Based Methods For Cannabinoid Production

May 5 (Reuters) - InMed Pharmaceuticals Inc:

* INMED PHARMACEUTICALS INC - WORKING WITH ALMAC GROUP ON PROPRIETARY APPROACH TO AUGMENT CURRENT BIOSYNTHESIS-BASED METHODS FOR CANNABINOID PRODUCTION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below